Eagle Pharmaceuticals, Inc. (OTCMKTS:EGRX – Get Free Report) crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.92 and traded as high as $3.9350. Eagle Pharmaceuticals shares last traded at $3.9350, with a volume of 1,635 shares changing hands.
Eagle Pharmaceuticals Stock Performance
The stock has a fifty day moving average price of $0.93 and a 200 day moving average price of $0.63. The stock has a market cap of $12.99 million, a PE ratio of 0.85 and a beta of 0.83.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc was a specialty pharmaceutical company focused on developing and commercializing injectable and intranasal medicines, with an emphasis on products intended to improve existing therapies through differentiated formulations, dosing approaches, or delivery technologies. The company primarily served hospital, oncology, emergency medicine, and critical-care markets.
Eagle’s marketed products included Ryanodex, an injectable formulation of dantrolene sodium used to treat malignant hyperthermia; Belrapzo, a formulation of bendamustine hydrochloride used in certain blood cancers; and Pemfexy, a ready-to-dilute formulation of pemetrexed used in the treatment of certain lung cancers and mesothelioma.
See Also
- Five stocks we like better than Eagle Pharmaceuticals
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
